◆ Premium Brief
Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
The Australian regulator, Therapeutic Goods Administration (TGA), has updated product information for certain diabetes and weight loss drugs to include a warning about a rare but severe eye disorder. The condition, known as non-arteritic anterior ischaemic optic neuropathy (NAION), has…
◆ Subscribe to read